← Open Payments lookup

CHRISTOPHER RANDOLPH: Open Payments

NPI 1669455606 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,021 in 52 payments from 13 companies in 2025. Trend: 2023 $1,128 · 2024 $641 · 2025 $1,021

Food & beverage: $1,021
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$283
Otsuka America Pharmaceutical, Inc.7$161
ABBVIE INC.13$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$127
Alkermes, Inc.3$70
Collegium Pharmaceutical, Inc.3$53
Teva Pharmaceuticals USA, Inc.3$52
Vertical Pharmaceuticals, LLC2$31
Supernus Pharmaceuticals, Inc.2$31
Corium, LLC1$21

Products named: INGREZZA, VRAYLAR, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, ARISTADA, Jornay PM, AUSTEDO XR.

Industry payments across AL — which companies pay providers there.